Improvement in sensitivity of allele-specific PCR facilitates reliable noninvasive prenatal detection of cystic fibrosis

Clinical Chemistry

Volumn 50, Issue 4, 2004, Pages 694-701

  Nasis, Ourania ^a,b   Thompson, Shanel ^a   Hong, Tom ^a   Sherwood, Margaret ^a   Radcliffe, Shawn ^a   Jackson, Laird ^a   Otevrel, Tomas ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; TAQ POLYMERASE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; ALLELE; ALLELE SPECIFIC POLYMERASE CHAIN REACTION; ARTICLE; CELL FREE SYSTEM; CHORION VILLUS; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA ISOLATION; FEMALE; FETUS; GENE MUTATION; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; MATERNAL BLOOD; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; ALLELES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; GESTATIONAL AGE; HUMANS; MALE; MUTATION; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 1842503944     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.025981     Document Type: Article

References (34)

1. Tabor A, Philip J, Madsen M, Bang J, Obel EB, Norgaard-Pedersen B. Randomized controlled trial of genetic amniocentesis in 4606 low risk women. Lancet 1986;1:1287-93.
2. Jackson LG, Wapner RJ. Risks of chorion villus sampling. Baillieres Clin Obstet Gynaecol 1987;1:513-31.
3. Carrera JM, Di Renzo GC. Recommendations and protocols for prenatal diagnosis. Prenat Neonat Med 1999;4:153-7.
4. Nanal R, Kyle P, Soothill P. A classification of pregnancy losses after invasive prenatal diagnostic procedures: an approach to allow comparison of units with a different case mix. Prenat Diagn 2003;23:488-92.
5. Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-7.
6. Bischoff FZ, Hahn S, Johnson KL, Simpson JL, Bianchi DW, Lewis DE, et al. Intact fetal cells in maternal plasma: are they really there? [Comment]. Lancet 2003;361:139-40.
7. Shulman LP. Fetal cells In maternal blood. Curr Womens Health Rep 2003;3:47-54.
8. Lo YMD, Patel P, Baigent CN, Gillmer MD, Chamberlain P, Travi M, et al. Prenatal sex determination from maternal peripheral blood using the polymerase chain reaction. Hum Genet 1993;90: 483-8.
9. Costa JM, Benachi A, Gautier E, Jouannic JM, Ernault P, Dumez Y. First-trimester fetal sex determination in maternal serum using real-time PCR. Prenat Diagn 2001;21:1070-4.
10. Sekizawa A, Kondo T, Iwasaki M, Watanabe A, Jimbo M, Saito H, et al. Accuracy of fetal gender determination by analysis of DNA in maternal plasma. Clin Chem 2001;47:1856-8.
11. Lo YMD, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma [Letter]. N Engl J Med 1998;10: 1734-8.
12. Bischoff FZ, Nguyen DD, Marquez-Do D, Moise KJJ, Simpson JL, Elias S. Noninvasive determination of fetal RhD status using fetal DNA in maternal serum and PCR. J Soc Gynecol Investig 1999;6: 64-9.
13. Costa JM, Giovangrandi Y, Ernault P, Lohmann L, Nataf V, El Halali N, et al. Fetal RHD genotyping in maternal serum during the first trimester of pregnancy. Br J Haematol 2002;119:255-60.
14. Amicucci P, Gennarelli M, Novelli G, Dallapiccola B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 2000;46:301-2.
15. Saito H, Sekizawa A, Morimoto T, Suzuki M, Yanaihara T. Prenatal DNA diagnosis of a single-gene from maternal plasma. Lancet 2000;356:1170.
16. Tang NL, Leung TN, Zhang J, Lau TK, Lo YMD. Detection of fetal derived paternally inherited X-chromosome polymorphism in maternal plasma. Clin Chem 1999;45:2033-5.
17. Chen CP, Chern SR, Wang W. Fetal DNA in maternal plasma: the prenatal detection of a paternally inherited fetal aneuploidy. Prenat Diagn 2000;20:355-7.
18. Chiu RWK, Lau TK, Leung TN, Chow KCK, Chui DHK, Lo YMD. Prenatal exclusion of β thalassaemla major by examination of maternal plasma. Lancet 2002;360:998-1000.
19. González-González MC, García-Hoyos M, Trujillo MJ, Rodríguez de Alba M, Lorda-Sánchez I, Díaz-Recasens J, et al. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat Diagn 2002;22:946-8.
20. González-González MC, Trujillo MJ, Rodríguez de Alba M, García-Hoyos M, Lorda-Sánchez I, Díaz-Recasens J, et al. Huntington disease - unaffected fetus diagnosed from maternal plasma using QF-PCR. Prenat Dlagn 2003;23:232-4.
21. Wu DY, Ugozzoli L, Pal BK, Wallace RB. Allele-specific enzymatic amplification of β-globin genomic DNA for diagnosis of sickle cell anemia. Proc Natl Acad Sci U S A 1989;86:2757-60.
22. Ayyadevara S, Thaden JJ, Shmookler Reis RJ. Discrimination of primer 3′-nucleotide mismatch by Taq DNA polymerase during polymerase chain reaction. Anal Biochem 2000;284:11-8.
23. Orou A, Fechner B, Utermann G, Menzel HJ. Allele-specific competitive blocker PCR: a one-step method with applicability to pool screening. Hum Mutat 1995;6:163-9.
24. Imyanitov EN, Buslov KG, Suspitsin EN, Kuligina ES, Belogubova EV, Grigoriev MY, et al. Improved reliability of allele-specific PCR. Biotechniques 2002;33:484-90.
25. McKinzie PB, Parsons BL. Detection of rare K-ras codon 12 mutations using allele-specific competitive blocker PCR. Mutat Res 2002;517:209-20.
26. Latorra D, Campbell K, Wolter A, Hurley JM. Enhanced allele-specific PCR discrimination in SNP genotyping using 3′ locked nucleic acid (LNA) primers. Hum Mutat 2003;22:79-85.
27. Cystic Fibrosis Mutation Database. http://www.genet.sickkids. on.ca/cftr (Accessed June 2003).
28. Chiu RWK, Poon LLM, Lau TK, Leung TN, Wong EMC, Lo YMD. Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem 2001;47:1607-13.
29. Zhong XY, Laivuori H, Livingston JC, Ylikorkala O, Sibai BM, Holzgreve W, et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol 2001;184:414-9.
30. Sambrook J, Russell DW. Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory Press, 2001:999pp.
31. Ariga H, Ohto H, Busch MP, Imamura S, Watson R, Reed W, et al. Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis. Transfusion 2001;41:1524-30.
32. Lo YMD, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-75.
33. Anonymous. High-specificity PCR, cycle after cycle, with AccuPrime Taq. Expressions 2001;8:2-3.
34. Park K, Lee J. AccuPrime Pfx: high-fidelity DNA polymerase with a zing. Focus 2003;25:10-3.